We then mutated K294 of COP1 to arginine (K294R, acetylation-dead mutant), which significantly impaired KAT6A-induced acetylation of COP1 in ovarian cancer cells (Figure 4H and 4K). This evidence concerns the gene KAT6A and ovarian carcinoma.